Detalus Advisors, LLC Pfizer Inc Transaction History

Detalus Advisors, LLC

$287 Million
Q3 2024

A detailed history of Detalus Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Detalus Advisors, LLC holds 9,682 shares of PFE stock, worth $258,896. This represents 0.1% of its overall portfolio holdings.

Number of Shares

9,682

Previous 25,044 61.34%

Holding current value

$258,896

Previous $700,000 60.0%

% of portfolio

0.1%

Previous 0.25%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$27.7 - $31.39 $425,527 - $482,213	-15,362 Reduced 61.34%	9,682 $280,000
Q2 2024 Jul 26, 2024	SELL	$25.26 - $29.6 $4,950 - $5,801	-196 Reduced 0.78%	25,044 $700,000
Q1 2024 Apr 24, 2024	BUY	$25.89 - $29.73 $6,265 - $7,194	242 Added 0.97%	25,240 $700,000
Q4 2023 Jan 24, 2024	SELL	$26.13 - $33.94 $144,734 - $187,993	-5,539 Reduced 18.14%	24,998 $719,000
Q3 2023 Oct 26, 2023	SELL	$32.09 - $37.51 $4,460 - $5,213	-139 Reduced 0.45%	30,537 $1.01 Million
Q2 2023 Jul 28, 2023	SELL	$36.12 - $41.79 $61,801 - $71,502	-1,711 Reduced 5.28%	30,676 $1.13 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $3,426 - $4,461	87 Added 0.27%	32,387 $1.32 Million
Q4 2022 Feb 09, 2023	SELL	$41.75 - $54.5 $27,972 - $36,515	-670 Reduced 2.03%	32,300 $1.66 Million
Q3 2022 Nov 04, 2022	BUY	$43.76 - $53.42 $1,837 - $2,243	42 Added 0.13%	32,970 $1.44 Million
Q2 2022 Jul 27, 2022	SELL	$46.53 - $55.17 $12,376 - $14,675	-266 Reduced 0.8%	32,928 $1.73 Million
Q1 2022 Apr 25, 2022	SELL	$45.75 - $56.69 $125,080 - $154,990	-2,734 Reduced 7.61%	33,194 $1.72 Million
Q4 2021 Jan 18, 2022	SELL	$41.32 - $61.25 $21,982 - $32,585	-532 Reduced 1.46%	35,928 $2.12 Million
Q3 2021 Oct 20, 2021	BUY	$39.25 - $50.42 $129,917 - $166,890	3,310 Added 9.98%	36,460 $1.57 Million
Q2 2021 Jul 14, 2021	BUY	$35.91 - $40.68 $208,888 - $236,635	5,817 Added 21.28%	33,150 $1.3 Million
Q1 2021 Apr 15, 2021	BUY	$33.49 - $37.77 $9,276 - $10,462	277 Added 1.02%	27,333 $990,000
Q4 2020 Jan 19, 2021	SELL	$33.47 - $42.56 $23,931 - $30,430	-715 Reduced 2.57%	27,056 $996,000
Q3 2020 Nov 18, 2020	BUY	$31.75 - $37.25 $11,239 - $13,186	354 Added 1.29%	27,771 $1.02 Million
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $54,577 - $66,210	1,812 Added 7.08%	27,417 $897,000
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $129,771 - $185,414	4,801 Added 23.08%	25,605 $836,000
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $684,867 - $777,237	20,804 New	20,804 $815,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Detalus Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Detalus Advisors, LLC with notifications on news.

Account

Detalus Advisors, LLC Pfizer Inc Transaction History